# EDGAR Filing Document

**Accession Number:** 0001182633
**File Stem:** 0001182633-25-000011
**Filing Date:** 2025-8
**Character Count:** 7567
**Document Hash:** 02d8e4845443ca46d0d229892476a32a
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001182633-25-000011.hdr.sgml**: 20250821

**ACCESSION NUMBER**: 0001182633-25-000011

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20250820

**FILED AS OF DATE**: 20250821

**DATE AS OF CHANGE**: 20250821

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** SHAROKY MELVIN MD
- **CENTRAL INDEX KEY:** 0001182633

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-30739
- **FILM NUMBER:** 251241558

**MAIL ADDRESS:**
- **STREET 1:** C/O INSMED INCORPORATED
- **STREET 2:** 700 US HIGHWAY 202/206
- **CITY:** BRIDGEWATER
- **STATE:** NJ
- **ZIP:** 08807
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** INSMED Inc
- **CENTRAL INDEX KEY:** 0001104506
- **STANDARD INDUSTRIAL CLASSIFICATION:** PHARMACEUTICAL PREPARATIONS [2834]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 541972729
- **STATE OF INCORPORATION:** VA
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 700 US HIGHWAY 202/206
- **CITY:** BRIDGEWATER
- **STATE:** NJ
- **ZIP:** 08807
- **BUSINESS PHONE:** 908-977-9900

**MAIL ADDRESS:**
- **STREET 1:** 700 US HIGHWAY 202/206
- **CITY:** BRIDGEWATER
- **STATE:** NJ
- **ZIP:** 08807

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** INSMED INC
- **DATE OF NAME CHANGE:** 20000128

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>SHAROKY MELVIN MD<br><sub>(Last) (First) (Middle)</sub><br>700 US HIGHWAY 202/206<br><sub>(Street)</sub><br>BRIDGEWATER, NJ 08807<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2025-08-20 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[X] Director [ ] 10% Owner<br>[ ] Officer (give title below) [ ] Other (specify below)<br>_ _ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>INSMED Inc [ INSM ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock | 2025-08-20 |  | S |  | 10000 | D | $129.50 | 274516 | D |  |
| Common Stock |  |  |  |  |  |  |  | 100 | I | By Melvin Sharoky C/F Owen F. Paley UTMA/FL<sup>(1)</sup> |
| Common Stock |  |  |  |  |  |  |  | 900 | I | By Baby Gator LLC<sup>(2)</sup> |
| Common Stock |  |  |  |  |  |  |  | 10000 | I | By Padonia, LLC<sup>(3)</sup> |
| Common Stock |  |  |  |  |  |  |  | 6847 | I | By spouse |
| Common Stock |  |  |  |  |  |  |  | 5180 | I | By Melvin Sharoky C/F Nolan M. Wink UTMA/FL<sup>(4)</sup> |
| Common Stock |  |  |  |  |  |  |  | 100 | I | By Melvin Sharoky C/F Wren J. Sharoky UTMA/FL<sup>(5)</sup> |
| Common Stock |  |  |  |  |  |  |  | 3481 | I | By Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL<sup>(6)</sup> |
| Common Stock |  |  |  |  |  |  |  | 576 | I | By Melvin Sharoky C/F Adler J. Wink UTMA/FL<sup>(7)</sup> |
| Common Stock |  |  |  |  |  |  |  | 100 | I | By Melvin Sharoky C/F Leo J. Sharoky UTMA/FL<sup>(8)</sup> |
| Common Stock |  |  |  |  |  |  |  | 4764 | I | By Melvin Sharoky C/F Sophie C. Wink UTMA/FL<sup>(9)</sup> |
| Common Stock |  |  |  |  |  |  |  | 100 | I | By Melvin Sharoky C/F Violet A. Paley UTMA/FL<sup>(10)</sup> |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

---

### Footnotes:

(1) The Reporting Person is the custodian of Melvin Sharoky C/F Owen F. Paley UTMA/FL.

(2) The Reporting Person is a managing member of Baby Gator LLC.

(3) The Reporting Person is the managing member of Padonia, LLC.

(4) The Reporting Person is the custodian of Melvin Sharoky C/F Nolan M. Wink UTMA/FL.

(5) The Reporting Person is the custodian of Melvin Sharoky C/F Wren J. Sharoky UTMA/FL.

(6) The Reporting Person is the custodian of Melvin Sharoky C/F Tulia L. Sharoky UTMA/FL.

(7) The Reporting Person is the custodian of Melvin Sharoky C/F Adler J. Wink UTMA/FL.

(8) The Reporting Person is the custodian of Melvin Sharoky C/F Leo J. Sharoky UTMA/FL.

(9) The Reporting Person is the custodian of Melvin Sharoky C/F Sophie C. Wink UTMA/FL.

(10) The Reporting Person is the custodian of Melvin Sharoky C/F Violet A. Paley UTMA/FL.

**Signature:** /s/ Melvin Sharoky, M.D, by Michael A. Smith as Attorney-in-fact  
**Date:** 2025-08-21

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**